[Use of estrogen-progestins in secondary prevention]

Ital Heart J Suppl. 2000 Mar;1(3):435-6.
[Article in Italian]
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Coronary Disease / prevention & control*
  • Double-Blind Method
  • Estrogen Replacement Therapy* / adverse effects
  • Estrogens, Conjugated (USP) / administration & dosage
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Medroxyprogesterone Acetate / administration & dosage
  • Middle Aged
  • Progesterone Congeners / administration & dosage
  • Risk Factors
  • Time Factors

Substances

  • Estrogens, Conjugated (USP)
  • Progesterone Congeners
  • Medroxyprogesterone Acetate